Investor Reaffirms Suit Accusing Akorn Execs Of Deceit
An Akorn Inc. investor told an Illinois federal court the pharmaceutical company's executives should not be able to dodge a suit alleging they lied in public statements for their own benefit,...To view the full article, register now.
Already a subscriber? Click here to view full article